Back to RXRX
Prime Capital Investment Advisors, LLC → RXRX
Prime Capital Investment Advisors, LLC RXRX Position History
Recursion Pharmaceuticals, Inc.
Quarters held
5
Latest value
$173K
Q3 2026
Peak value
$173K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $134K |
| Q4 2025 | $114K |
| Q1 2026 | $81K |
| Q2 2026 | $43K |
| Q3 2026 | $173K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $173K | 41.9K | — | — |
| Q2 2026 | $43K | 11.6K | — | — |
| Q1 2026 | $81K | 26.5K | — | — |
| Q4 2025 | $114K | 27.9K | — | — |
| Q3 2025 | $134K | 27.4K | — | — |
Other funds holding RXRX
Other Prime Capital Investment Advisors, LLC positions
ETHA
$710.3MISHARES TR CORE S&P500 ETF
ETHA
$708.4MISHARES TR CORE S&P500 ETF
ETHA
$490MISHARES TR CORE US AGGBD ET
VGES
$393.7MVANGUARD INDEX FDS TOTAL STK MKT
VGES
$387.4MVANGUARD INDEX FDS TOTAL STK MKT
VGES
$381MVANGUARD INDEX FDS MRNGSTR TTL STK
ETHA
$380.2MISHARES TR CORE US AGGBD ET
ETHA
$375.8MISHARES TR CORE US AGGBD ET